Brief: DBP gets SEK 0.5 mln project funds for developing liver cancer drug
28/04/2017 08:38
April 28 (Reuters) - DOUBLE BOND PHARMACEUTICAL INTERNATIONAL AB (PUBL) DBPHAb.ST :
* SAID ON THURSDAY IT GOT SEK 0.5 MILLION OF PROJECT FUNDS FROM VINNOVA
* GRANT IS TO BE USED FOR DEVELOPMENT OF LIVER CANCER DRUG SA-033
* SA-033 IS DEVELOPED WITHIN DBP'S HORIZON2020 SME INSTRUMENT
Source text: http://bit.ly/2p9UaQC
Further company coverage: DBPHAb.ST
(Gdynia Newsroom)
((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Double Bond Pharmaceutical International AB (publ)
See all newsBrief: DBP International AB And Vivo Biopharma LLC Revised Asset Purchase And Collaboration Agreements
Brief: DBP International AB And Vivo Biopharma LLC Enter Into Asset Purchase And Collaboration Agreements To Develop And Commercialize A Novel Glioblastoma Treatment
Brief: DBP And Vivo Enter Into Asset Purchase And Collaboration Agreements To Develop And Commercialize A Novel Glioblastoma Treatment
Brief: Double Bond Pharmaceutical Says Positive Response For SI-053 From Ethical Committee In Netherlands Has Been Received
Brief: Double Bond To Cooperate With Belarus State Medical University